Compare NCEL & MNTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCEL | MNTS |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 20.3M |
| IPO Year | N/A | N/A |
| Metric | NCEL | MNTS |
|---|---|---|
| Price | $2.59 | $8.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 90.9K | ★ 586.5K |
| Earning Date | 12-01-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,032,000.00 |
| Revenue This Year | N/A | $286.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.48 | $7.35 |
| 52 Week High | $7.64 | $183.86 |
| Indicator | NCEL | MNTS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 93.85 |
| Support Level | N/A | $0.44 |
| Resistance Level | N/A | $9.80 |
| Average True Range (ATR) | 0.00 | 0.58 |
| MACD | 0.00 | 0.97 |
| Stochastic Oscillator | 0.00 | 87.51 |
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.